Ocular prostaglandin production and morphology in mice lacking a single isoform of cyclooxygenase

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 5-6, 2009, Pages 401-409

  Cryan, Lorna M ^a   Fitzgerald, Desmond J ^b   O'Brien, Colm ^b,c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Eicosanoids; Histology; Knockout mice; Ocular tissue

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; ISOENZYME; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; EYE DEVELOPMENT; GENOTYPE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LENS; MOUSE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SYNTHESIS; RETINA; SCLERA; TISSUE LEVEL; UVEA; WILD TYPE;

AGE FACTORS; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EYE; GENOTYPE; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; TISSUE DISTRIBUTION;

MUS;

EID: 71749115763     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.08.001     Document Type: Article

References (45)

1. Funk C.D., Funk L.B., Kennedy M.E., Pong A.S., and Fitzgerald G.A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB. J. 5 (1991) 2304-2312
2. Yermakova A.V., Rollins J., Callahan L.M., Rogers J., and O'Banion M.K. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J. Neuropathol. Exp. Neurol. 58 (1999) 1135-1146
3. Kirschenbaum A., Klausner A.P., Lee R., et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 56 (2000) 671-676
4. Tamura M., Sebastian S., Gurates B., Yang S., Fang Z., and Bulun S.E. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J. Clin. Endocrinol. Metab. 87 (2002) 3504-3507
5. Lukiw W.J., Ottlecz A., Lambrou G., et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4163-4170
6. Inoue H., Yokoyama C., Hara S., Tone Y., and Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase- 2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 270 (1995) 24965-24971
7. Schlotzer-Schrehardt U., Zenkel M., and Nusing R.M. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1475-1487
8. Kyveris A., Maruscak E., and Senchyna M. Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR. Mol. Vis. 8 (2002) 51-58
9. Toris C.B., Camras C.B., and Yablonski M.E. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology 100 (1993) 1297-1304
10. Fleisher L.N., Ferrell J.B., Smith M.G., and McGahan M.C. Lipid mediators of tumor necrosis factor-alpha-induced uveitis. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2393-2399
11. Steigerwalt Jr. R.D., Belcaro G.V., Christopoulos V., Incandela L., Cesarone M.R., and De Sanctis M.T. Ocular and orbital blood flow velocity in patients with peripheral vascular disease and diabetes treated with intravenous prostaglandin E1. J. Ocul. Pharmacol. Ther. 17 (2001) 529-535
12. Knox F.A., Barry M., McGowan B., and O'Brien C. The rising cost of glaucoma drugs in Ireland 1996-2003. Br. J. Ophthalmol. 90 (2006) 162-165
13. Woodward D.F., Krauss A.H., Chen J., et al. The pharmacology of bimatoprost (Lumigan). Surv. Ophthalmol. 45 Suppl. 4 (2001) S337-S345
14. Solomon K.D., Turkalj J.W., Whiteside S.B., Stewart J.A., and Apple D.J. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch. Ophthalmol. 115 (1997) 1119-1122
15. Jaramillo A., Bhattacherjee P., Sonnenfeld G., and Paterson C.A. Modulation of immune responses by cyclo-oxygenase inhibitors during intraocular inflammation. Curr. Eye Res. 11 (1992) 571-579
16. Karon M.D., and Klyce S.D. Effect of inhibition of inflammatory mediators on trauma-induced stromal edema. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2507-2511
17. Ueda M., Sugatani J., Unezaki S., et al. Involvement of prostaglandin E2 in rabbit corneal injury by anterior segment ischaemia. Prostaglandins Leukot. Essent. Fatty Acids 57 (1997) 285-291
18. Ke T.L., Graff G., Spellman J.M., and Yanni J.M. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Inflammation 24 (2000) 371-384
19. Ju W.K., and Neufeld A.H. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. J. Comp. Neurol. 452 (2002) 392-399
20. Kass M.A., and Holmberg N.J. Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues. Invest. Ophthalmol. Vis. Sci. 18 (1979) 166-171
21. Sennlaub F., Valamanesh F., Vazquez-Tello A., et al. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108 (2003) 198-204
22. Cryan L.M., Pidgeon G.P., Fitzgerald D.J., and O'Brien C.J. COX-2 protects against thrombosis of the retinal vasculature in a mouse model of proliferative retinopathy. Mol. Vis. 12 (2006) 405-414
23. Kern T.S., Miller C.M., Du Y., et al. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56 (2007) 373-379
24. Marshall J.C., Fernandes B.F., Di Cesare S., et al. The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma. Carcinogenesis (2007)
25. Langenbach R., Morham S.G., Tiano H.F., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83 (1995) 483-492
26. Morham S.G., Langenbach R., Loftin C.D., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83 (1995) 473-482
27. Belton O.A., Duffy A., Toomey S., and Fitzgerald D.J. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation 108 (2003) 3017-3023
28. Loftin C.D., Trivedi D.B., Tiano H.F., et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1059-1064
29. Amico C., Yakimov M., Catania M.V., Giuffrida R., Pistone M., and Enea V. Differential expression of cyclooxygenase-1 and cyclooxygenase-2 in the cornea during wound healing. Tissue Cell 36 (2004) 1-12
30. Neufeld A.H., Jumblatt M.M., Matkin E.D., and Raymond G.M. Maintenance of corneal endothelial cell shape by prostaglandin E2: effects of EGF and indomethacin. Invest. Ophthalmol. Vis. Sci. 27 (1986) 1437-1442
31. Lu J., Lu Z., Reinach P., et al. TGF-beta2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation. Exp. Cell. Res. 312 (2006) 3631-3640
32. Parnigotto P.P., and Conconi M.T. Effects of prostaglandin E2 on growth, morphology, morphometry and keratin pattern of bovine corneal epithelial cells cultured in vitro. Ann. Anat. 180 (1998) 511-518
33. Mieyal P.A., Bonazzi A., Jiang H., Dunn M.W., and Schwartzman M.L. The effect of hypoxia on endogenous corneal epithelial eicosanoids. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2170-2176
34. van Haeringen N.J., van Sorge A.A., and Carballosa V.M. Core-Bodelier, Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen. J. Ocul. Pharmacol. Ther. 16 (2000) 353-361
35. Maihofner C., Schlotzer-Schrehardt U., Guhring H., et al. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2616-2624
36. Biswas S., Bhattacherjee P., and Paterson C.A. Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues-a comparative immunohistochemical study. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 277-288
37. Mukhopadhyay P., Bian L., Yin H., Bhattacherjee P., and Paterson C. Localization of EP(1) and FP receptors in human ocular tissues by in situ hybridization. Invest. Ophthalmol. Vis. Sci. 42 (2001) 424-428
38. Crowston J.G., Lindsey J.D., Aihara M., and Weinreb R.N. Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3555-3559
39. Crowston J.G., Lindsey J.D., Morris C.A., Wheeler L., Medeiros F.A., and Weinreb R.N. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4571-4577
40. Kulkarni P.S., and Srinivasan B.D. Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva. Prog. Clin. Biol. Res. 312 (1989) 39-52
41. Fleischhauer J.C., Mitchell C.H., Peterson-Yantorno K., Coca-Prados M., and Civan M.M. PGE(2), Ca(2+), and cAMP mediate ATP activation of Cl(-) channels in pigmented ciliary epithelial cells. Am. J. Physiol. Cell Physiol. 281 (2001) C1614-C1623
42. Kaplan-Messas A., Naveh N., Avni I., and Marshall J. Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye. Eur. J. Ophthalmol. 13 (2003) 18-23
43. Yousufzai S.Y., Ye Z., and Abdel-Latif A.A. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp. Eye Res. 63 (1996) 305-310
44. Damm J., Rau T., Maihofner C., Pahl A., and Brune K. Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body. Exp. Eye Res. 72 (2001) 611-621
45. Joussen A.M., Poulaki V., Mitsiades N., et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB. J. 16 (2002) 438-440